|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Trading: CLOSE LONG @ $0.15
Signal Strength: MEDIUM
Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.
Impedimed (ASX:IPD) current trading has closed out Envelope Bands to overbought status and signalled the initiation of short trading conditions. Currently, the Upper Band is 0.1575.
Moving Average Envelopes are percentage-based envelopes set above and below a moving average. The moving average which forms the base for this indicator can be a simple or exponential moving average. Each envelope is then set the same percentage above or below the moving average. This creates parallel bands that follow price action. With a moving average as the base Moving Average Envelopes can be used as a trend following indicator.
Calculation: Moving Average Envelope:
1) Upper Envelope: 20-day SMA + (20-day SMA x .025);
2) Lower Envelope: 20-day SMA - (20-day SMA x .025);
PROFILE: Impedimed (IPD.AX)
Stock Exchange: ASX
Ticker Codes: | IPD.AX | ASX:IPD |
ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
|MXI Maxitra Industries||0.33||8.2||24,282||100||BULLISH|
|SLR Silver Lake Resources||1.45||8.2||9,252,383||294.64||BULLISH|
|RSG Resolute Mining||1.74||7.1||9,161,059||279.41||BULLISH|
|PRU Perseus Mining||0.71||6.8||12,414,565||224.14||BULLISH|
|AQG Alacer Gold Corp||5.42||6.3||936,317||165.59||BULLISH|
|NST Northern Star Resources||13.47||6||4,840,454||194.15||BULLISH|
|WAF West African Resources||0.39||5.4||3,897,020||181.82||BULLISH|
|SBM St Barbara Mines||3.55||5.3||5,019,351||105.92||BULLISH|
|AGG Anglogold Ashanti||5.56||5.1||467,306||168.07||BULLISH|
|RRL Regis Resources||6.38||4.9||5,376,386||179.3||BULLISH|